ArticleThe Lancet. Oncology2022
Tissue-agnostic RET inhibition: can you trust your target?
Angelica D'Aiello et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2022
Angelica D'Aiello et al.PubMed ↗Publisher ↗
No numbers read from the abstract.